Internal Reference Number: FOI_8635
Date Request Received: 09/05/2025 00:00:00
Date Request Replied To: 20/05/2025 00:00:00
This response was sent via: By Email
Request Summary: Request on intra-vitreal injections or implants
Request Category: Researcher
| Question Number 1: How many of the following intra-vitreal injections/implants has your trust administered in the four-month period from January to April 2025: • Aflibercept • Bevacizumab • Brolucizumab • Dexamethasone • Faricimab • Fluocinolone acetonide • Ranibizumab - Lucentis • Ranibizumab - Biosimilar (Ongavia, Ximluci, Byooviz, Rimmyrah) | |
| Answer To Question 1: • Aflibercept 1205 • Bevacizumab 8 • Brolucizumab 0 • Dexamethasone 7 • Faricimab 1019 • Fluocinolone acetonide 0 • Ranibizumab - Lucentis <5 • Ranibizumab - Biosimilar (Ongavia, Ximluci, Byooviz, Rimmyrah) 0 | |
| Question Number 2: Please provide the number of injections/implants by eye condition for the four-month period from January to April 2025: (see attached) | |
| Answer To Question 2: See attached. To accompany this answer to question 2 please also see the documents listed below:  8635 - Q2 response sheet completed.pdf | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
